Epilepsy and the medications to manage it are associated with osteoporosis

Publicly released:
International
Photo by CHUTTERSNAP on Unsplash
Photo by CHUTTERSNAP on Unsplash

Both epilepsy itself and anti-seizure medications (ASMs) used to manage the condition are associated with an increased risk of osteoporosis, according to international researchers. The team collected data from over 6000 people with epilepsy and looked at the rate of osteoporosis compared to the general population, accounting for a range of other health factors that could increase their osteoporosis risk. They also investigated how two types of ASMs impacted osteoporosis risk; enzyme-inducing ASMs aimed at speeding up the metabolism of the drug, and non-enzyme-inducing ASMs. The researchers say independent of anti-seizure medications, people with epilepsy developed osteoporosis 41% faster overall than the general population. Both ASMs were also independently associated with osteoporosis, they say, with the effect greater for non-enzyme-inducing ASMs.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Neurology
Research:Paper
Organisation/s: University of Calgary, Canada
Funder: This analysis was funded in part through an internal grant from the University of Calgary (Dr Josephson).
Media Contact/s
Contact details are only visible to registered journalists.